Sanjay Chatterjee
58, Canal Circular Road
Kolkata, WB 700054, India
Kolkata, WB 700054, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Screening for Hepatic Steatosis and Fibrosis Among Physicians Attending the Integrated Diabetes and Endocrine Academy Conference: A Cross-Sectional Study.
Journal: Cureus
Published: June 15, 2026
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.
Journal: Expert review of clinical pharmacology
Published: March 12, 2024
One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India-TRUST (Tresiba real-world use study).
Journal: Metabolism open
Published: February 14, 2022
Practical aspects of usage of insulin in India: Descriptive review and key recommendations.
Journal: Diabetes & metabolic syndrome
Published: December 01, 2020
Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement.
Journal: Diabetes & metabolic syndrome
Published: December 17, 2019
Sudden Renal Failure in a Scleroderma Patient: A Clinical Dilemma.
Journal: The Journal of the Association of Physicians of India
Published: July 21, 2019
Systemic Thrombolysis for Pulmonary Embolism: Evidence, Patient Selection, and Protocols for Management.
Journal: Interventional cardiology clinics
Published: November 22, 2017
Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?"
Journal: The Journal of the Association of Physicians of India
Published: August 10, 2017
ACP Journal Club. Review: More- vs less-intensive BP-lowering regimens reduce major CV events.
Journal: Annals of internal medicine
Published: February 17, 2016
ACP Journal Club. In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control reduced CV events and mortality.
Journal: Annals of internal medicine
Published: February 17, 2016
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome.
Journal: World journal of diabetes
Published: February 13, 2016
Last Updated: 09/26/2026